Related Experiment Video

Updated: Aug 10, 2026

Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection
07:06

Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection

Published on: December 8, 2014

Elevated tacrolimus trough levels in association with mycophenolate mofetil-induced diarrhea: a case report

M Frühwirth1, H Fischer, B Simma

  • 1Department of Pediatrics, University Hospital Innsbruck, Anichstrasse 35, A-6020 Innsbruck, Austria. Martin.Fruehwirth@uibk.ac.at

Pediatric Transplantation
|May 1, 2001
PubMed

Insights

Tacrolimus and mycophenolate mofetil are common immunosuppressants. Mycophenolate mofetil-induced diarrhea can increase tacrolimus levels, requiring dose adjustments and monitoring after kidney transplants.

Area of Science:

  • Pharmacology
  • Transplantation Medicine
  • Nephrology

Background:

  • Tacrolimus (TAC) and mycophenolate mofetil (MMF) are standard immunosuppressants post-organ transplantation.
  • The pharmacokinetic interactions between TAC and MMF are not well understood.
  • Effective immunosuppression is crucial for preventing organ rejection.

Observation:

  • A case study of an 8-year-old boy following a kidney transplant is presented.
  • The patient experienced diarrhea attributed to MMF treatment.
  • Elevated tacrolimus (TAC) trough levels were observed during the period of MMF-induced diarrhea.

Findings:

  • MMF-induced diarrhea can significantly alter TAC pharmacokinetics.
  • Diarrhea may lead to increased TAC absorption or reduced clearance, resulting in higher drug concentrations.
  • This interaction highlights a potential risk for TAC toxicity in transplant recipients.

Implications:

  • Close monitoring of TAC trough levels is essential in transplant patients experiencing diarrhea, particularly those on MMF.
  • Early dose reduction of TAC may be necessary to prevent toxicity during episodes of MMF-induced diarrhea.
  • Further research into the mechanisms of TAC-MMF interaction is warranted to optimize immunosuppressive therapy.

More Related Videos

Quantification of the Immunosuppressant Tacrolimus on Dried Blood Spots Using LC-MS/MS08:38

Quantification of the Immunosuppressant Tacrolimus on Dried Blood Spots Using LC-MS/MS

Published on: November 8, 2015

Therapeutic Evaluation of Fecal Microbiota Transplantation in an Interleukin 10-Deficient Mouse Model05:41

Therapeutic Evaluation of Fecal Microbiota Transplantation in an Interleukin 10-Deficient Mouse Model

Published on: April 6, 2022

Related Concept Videos

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel Disease...
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...